Cargando…

Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease

Parkinson’s disease (PD) is driven by dopaminergic neurodegeneration in the substantia nigra pars compacta (SN) and striatum. Although apoptosis is considered the main neurodegenerative mechanism, other cell death pathways may be involved. In this regard, necroptosis is a regulated form of cell deat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dionísio, Pedro A., Oliveira, Sara R., Gaspar, Maria M., Gama, Maria J., Castro-Caldas, Margarida, Amaral, Joana D., Rodrigues, Cecilia M. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831575/ https://www.ncbi.nlm.nih.gov/pubmed/31690718 http://dx.doi.org/10.1038/s41419-019-2078-z

Ejemplares similares

Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice
por: Oliveira, Sara R., et al.
Publicado: (2021)

miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
por: Oliveira, Sara R., et al.
Publicado: (2021)

Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration
por: Tsika, Elpida, et al.
Publicado: (2014)

TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
por: He, Xin, et al.
Publicado: (2021)

miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease
por: Hu, Yong-Bo, et al.
Publicado: (2019)

Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
por: Yuan, Yu, et al.
Publicado: (2023)

Neural ablation of the PARK10 candidate Plpp3 leads to dopaminergic transmission deficits without neurodegeneration
por: Gómez-López, Sandra, et al.
Publicado: (2016)

Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology
por: Oliveira, Sara R., et al.
Publicado: (2020)

Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease
por: Gong, Xin, et al.
Publicado: (2022)

The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration
por: Wang, Xin, et al.
Publicado: (2023)

Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses
por: Yan, Junqiang, et al.
Publicado: (2011)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease Models
por: Neal, Matthew L., et al.
Publicado: (2023)

Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson’s disease
por: Wu, Kuo-Jen, et al.
Publicado: (2023)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
por: Kolacheva, Anna, et al.
Publicado: (2022)

Fluorescence microscopy-based sensitive method to quantify dopaminergic neurodegeneration in a Drosophila model of Parkinson’s disease
por: Ayajuddin, Mohamad, et al.
Publicado: (2023)

Activation of necroptosis in human and experimental cholestasis
por: Afonso, Marta B, et al.
Publicado: (2016)

RIP1/RIP3/MLKL Mediates Myocardial Function Through Necroptosis in Experimental Autoimmune Myocarditis
por: Wu, Yujing, et al.
Publicado: (2021)

Exposure to Mitochondrial Genotoxins and Dopaminergic Neurodegeneration in Caenorhabditis elegans
por: González-Hunt, Claudia P., et al.
Publicado: (2014)

The Role of Autophagy Dysregulation in Manganese-Induced Dopaminergic Neurodegeneration
por: Zhang, Jianbin, et al.
Publicado: (2013)

Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans
por: Cheon, Se-Myeong, et al.
Publicado: (2016)

Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence
por: Machado, A., et al.
Publicado: (2011)

PET Analysis of Dopaminergic Neurodegeneration in Relation to Immobility in the MPTP-Treated Common Marmoset, a Model for Parkinson’s Disease
por: Ando, Kiyoshi, et al.
Publicado: (2012)

Tat-Fused Recombinant Human SAG Prevents Dopaminergic Neurodegeneration in a MPTP-Induced Parkinson’s Disease Model
por: Sohn, Eun Jeong, et al.
Publicado: (2014)

Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson’s disease
por: Huang, Dongping, et al.
Publicado: (2019)

Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
por: Nguyen, An Phu Tran, et al.
Publicado: (2020)

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease
por: Peng, Qinyu, et al.
Publicado: (2022)

Mechanistic impacts of bacterial diet on dopaminergic neurodegeneration in a Caenorhabditis elegans α-synuclein model of Parkinson’s disease
por: Gaeta, Anthony L., et al.
Publicado: (2023)

RIP3-mediated microglial necroptosis promotes neuroinflammation and neurodegeneration in the early stages of diabetic retinopathy
por: Huang, Zijing, et al.
Publicado: (2023)

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
por: Spittau, Björn
Publicado: (2015)

Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration
por: Chen, Xi, et al.
Publicado: (2019)

Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson’s Disease
por: Javed, Hayate, et al.
Publicado: (2019)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Investigating Bacterial Sources of Toxicity as an Environmental Contributor to Dopaminergic Neurodegeneration
por: Caldwell, Kim A., et al.
Publicado: (2009)

Erratum to: The Role of Autophagy Dysregulation in Manganese-Induced Dopaminergic Neurodegeneration
por: Zhang, Jianbin, et al.
Publicado: (2014)

The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration
por: Tu, Dezhen, et al.
Publicado: (2019)

An unbiased, automated platform for scoring dopaminergic neurodegeneration in C. elegans
por: Clark, Andrew S., et al.
Publicado: (2023)

An unbiased, automated platform for scoring dopaminergic neurodegeneration in C. elegans
por: Clark, Andrew S., et al.
Publicado: (2023)

Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease
por: Videira, Paula A. Q., et al.
Publicado: (2018)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uvkid5vs3aunegm1jiapeoknug